KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Short term Debt (2016 - 2021)

Staar Surgical's Short term Debt history spans 12 years, with the latest figure at $1.3 million for Q4 2021.

  • For Q4 2021, Short term Debt fell 5.25% year-over-year to $1.3 million; the TTM value through Oct 2021 reached $1.3 million, down 5.25%, while the annual FY2021 figure was $1.4 million, 24.52% down from the prior year.
  • Short term Debt reached $1.3 million in Q4 2021 per STAA's latest filing, roughly flat from $1.3 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $4.7 million in Q1 2018 to a low of $1.3 million in Q3 2021.
  • Average Short term Debt over 5 years is $2.9 million, with a median of $2.9 million recorded in 2019.
  • Peak YoY movement for Short term Debt: increased 5.19% in 2018, then plummeted 59.78% in 2020.
  • A 5-year view of Short term Debt shows it stood at $4.4 million in 2017, then fell by 14.83% to $3.8 million in 2018, then plummeted by 38.1% to $2.3 million in 2019, then plummeted by 42.18% to $1.4 million in 2020, then decreased by 5.25% to $1.3 million in 2021.
  • Per Business Quant, the three most recent readings for STAA's Short term Debt are $1.3 million (Q4 2021), $1.3 million (Q3 2021), and $1.3 million (Q2 2021).